Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.89
Delayed Data
As of Oct 20
 0.00 / 0.00%
Today’s Change
1.56
Today|||52-Week Range
10.90
-64.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash18.0M16.5M12.7M13.6M
 
 
 
 
 
Short Term Investment Cash2.1M-1.5M-3.8M862.0K
 
 
 
 
 
Cash & Short Term Investments18.0M16.5M12.7M13.6M
 
 
 
 
 
 
ReceivablesReceivables3.5M2.1M3.3M1.0M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses845.0K867.0K705.0K1.1M
 
 
 
 
 
Other Current Assets161.0K173.0K269.0K332.0K
 
 
 
 
 
Current Assets22.6M19.6M17.0M16.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--6.4M----
 
 
Depreciation---6.3M----
 
 
Other Assets0.000.000.000.00--
Total Assets22.7M19.7M17.1M16.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.0M2.5M1.7M2.0M
 
 
 
 
 
Accrued Expenses3.4M2.3M2.1M2.1M
 
 
 
 
 
Other Current Liabilities3.6M2.8M2.5M2.3M
 
 
 
 
 
Other Liabilities5.6M5.3M4.1M4.3M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities141.0K130.0K127.0K128.0K
 
 
 
 
 
Total Liabilities5.7M5.4M4.3M4.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity16.9M14.3M12.8M11.6M
 
 
 
 
 
Total Shareholder Equity16.9M14.3M12.8M11.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding4.3M4.3M4.3M4.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.